# Treatment of Multiple Sclerosis With Copaxone and Albuterol

> **NCT00039988** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (actual)

## Conditions studied

- Autoimmune Diseases
- Multiple Sclerosis

## Interventions

- **DRUG:** Glatiramer acetate
- **DRUG:** Albuterol
- **DRUG:** Albuterol placebo

## Key facts

- **NCT ID:** NCT00039988
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2006-03
- **Final completion:** 2007-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00039988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00039988, "Treatment of Multiple Sclerosis With Copaxone and Albuterol". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00039988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*